One-carbon metabolism and breast cancer: an epidemiological perspective

Xinran Xu^a,
Jia Chen^{a, b, c
, ,}

a.
Department of Community and Preventive Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA
b.
Department of Pediatrics, Mount Sinai School of Medicine, New York, NY 10029, USA
c.
Department of Oncological Science, Mount Sinai School of Medicine, New York, NY 10029, USA

More Information

Corresponding author: E-mail address: jia.chen@mssm.edu (Jia Chen)

摘要

- /
- /
- /
- /
- /
Abstract: One-carbon metabolism is a network of biological reactions that plays critical role in DNA methylation and DNA synthesis, and in turn, facilitates the cross-talk between genetic and epigenetic processes. Genetic polymorphisms and supplies of cofactors (e.g. folate, vitamins B) involved in this pathway have been shown to influence cancer risk and even survival. In this review, we summarized the epidemiological evidence for one-carbon metabolism, from both genetics and lifestyle aspects, in relation to breast cancer risk. We also discussed this pathway in relation to breast cancer survival and the modulation of one-carbon polymorphism in chemotherapy. Emerging evidence on modulation of DNA methylation by one-carbon metabolism suggests that disruption of epigenome might have been the underlying mechanism. More results are expected and will be translated to guidance to the general population for disease prevention as well as to clinicians for treatment and management of the disease.
- one-carbon /
- breast cancer /
- folate /
- genetic polymorphism /
- DNA methylation /
- epidemiology

HTML全文

参考文献(87)

[1]	Bailey, L.B., Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: Metabolic significance, risks and impact on folate requirement J. Nutr., 129 (1999),pp. 919-922
[2]	Baylin, S.B., Herman, J.G., Graff, J.R. et al. Alterations in DNA methylation: A fundamental aspect of neoplasia Adv. Cancer Res., 72 (1998),pp. 141-196
[3]	Baylin, S.B., Esteller, M., Rountree, M.R. et al. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer Hum. Mol. Genet., 10 (2001),pp. 687-692
[4]	Blount, B.C., Mack, M.M., Wehr, C.M. et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: Implications for cancer and neuronal damage Proc. Natl. Acad. Sci. USA, 94 (1997),pp. 3290-3295
[5]	Castro, R., Rivera, I., Ravasco, P. et al. J. Med. Genet., 41 (2004),pp. 454-458
[6]	Chabner, B.
[7]	Chen, J., Stampfer, M.J., Ma, J. et al. Influence of a methionine synthase (D919G) polymorphism on plasma homocysteine and folate levels and relation to risk of myocardial infarction Atherosclerosis, 154 (2001),pp. 667-672
[8]	Chen, J., Gammon, M.D., Chan, W. et al. Cancer Res., 65 (2005),pp. 1606-1614
[9]	Cho, E., Holmes, M., Hankinson, S.E. et al. Nutrients involved in one-carbon metabolism and risk of breast cancer among premenopausal women Cancer Epidemiol. Biomarkers Prev., 16 (2007),pp. 2787-2790
[10]	Christman, J.K., Sheikhnejad, G., Dizik, M. et al. Reversibility of changes in nucleic acid methylation and gene expression induced in rat liver by severe dietary methyl deficiency Carcinogenesis, 14 (1993),pp. 551-557
[11]	Clarke, R.
[12]	Combs, G.F.
[13]	Davis, C.D., Uthus, E.O. DNA methylation, cancer susceptibility, and nutrient interactions Exp. Biol. Med., 229 (2004),pp. 988-995
[14]	Demark-Wahnefried, W., Peterson, B., McBride, C. et al. Current health behaviors and readiness to pursue life-style changes among men and women diagnosed with early stage prostate and breast carcinomas Cancer, 88 (2000),pp. 674-684
[15]	Ericson, U., Sonestedt, E., Gullberg, B. et al. High folate intake is associated with lower breast cancer incidence in postmenopausal women in the Malmo Diet and Cancer cohort Am. J. Clin. Nutr., 86 (2007),pp. 434-443
[16]	Esteller, M. Epigenetics in Cancer N. Engl. J. Med., 358 (2008),pp. 1148-1159
[17]	Fowler, B.M., Giuliano, A.R., Piyathilake, C. et al. Hypomethylation in cervical tissue: Is there a correlation with folate status? Cancer Epidemiol Biomarkers Prev., 7 (1998),pp. 901-906
[18]	Frosst, P., Blom, H.J., Milos, R. et al. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase Nat. Genet., 10 (1995),pp. 111-113
[19]	Gaughan, D.J., Kluijtmans, L.A., Barbaux, S. et al. Atherosclerosis, 157 (2001),pp. 451-456
[20]	Goode, E.L., Potter, J.D., Bigler, J. et al. Methionine synthase D919G polymorphism, folate metabolism, and colorectal adenoma risk Cancer Epidemiol. Biomarkers Prev., 13 (2004),pp. 157-162
[21]	Halsted, C.H., Villanueva, J.A., Devlin, A.M. et al. Metabolic interactions of alcohol and folate J. Nutr., 132 (2002),pp. 2367S-2372S
[22]	Hanahan, D., Weinberg, R.A. The hallmarks of cancer Cell, 100 (2000),pp. 57-70
[23]	Hannon-Fletcher, M.P., Armstrong, N.C., Scott, J.M. et al. Determining bioavailability of food folates in a controlled intervention study Am. J. Clin. Nutr., 80 (2004),pp. 911-918
[24]	Harmon, D.L., Shields, D.C., Woodside, J.V. et al. Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations Genet. Epidemiol., 17 (1999),pp. 298-309
[25]	Herman, J.G. Hypermethylation of tumor suppressor genes in cancer Semin. Cancer Biol., 9 (1999),pp. 359-367
[26]	Horie, N., Aiba, H., Oguro, K. et al. Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5′-terminal regulatory region of the human gene for thymidylate synthase Cell Struct. Funct., 20 (1995),pp. 191-197
[27]	Institute of Medicine
[28]	Jacob, R.A., Gretz, D.M., Taylor, P.C. et al. Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women J. Nutr., 128 (1998),pp. 1204-1212
[29]	Jacques, P.F., Bostom, A.G., Selhub, J. et al. Effects of polymorphisms of methionine synthase and methionine synthase reductase on total plasma homocysteine in the NHLBI Family Heart Study Atherosclerosis, 166 (2003),pp. 49-55
[30]	Johnson, W.G., Stenroos, E.S., Spychala, J.R. et al. Am. J. Med. Genet. A, 124 (2004),pp. 339-345
[31]	Justenhoven, C., Hamann, U., Pierl, C.B. et al. Cancer Epidemiol. Biomarkers Prev., 14 (2005),pp. 3015-3018
[32]	Kaneda, S., Takeishi, K., Ayusawa, D. et al. Role in translation of a triple tandemly repeated sequence in the 5′-untranslated region of human thymidylate synthase mRNA Nuclear Acids Res., 15 (1987),pp. 1259-1270
[33]	Kawakami, K., Ruszkiewicz, A., Bennett, G. et al. The folate pool in colorectal cancers is associated with DNA hypermethylation and with a polymorphism in methylenetetrahydrofolate reductase Clin. Cancer Res., 9 (2003),pp. 5860-5865
[34]	Lajous, M., Romieu, I., Sabia, S. et al. Folate, vitamin B12 and postmenopausal breast cancer in a prospective study of French women Cancer Causes Control, 17 (2006),pp. 1209-1213
[35]	Larsson, S.C., Giovannucci, E., Wolk, A. Folate and risk of breast cancer: A meta-analysis J. Natl. Cancer Inst., 99 (2007),pp. 64-76
[36]	Lewis, S.J., Harbord, R.M., Harris, R. et al. Meta-analyses of observational and genetic association studies of folate intakes or levels and breast cancer risk J. Natl. Cancer Inst., 98 (2006),pp. 1607-1622
[37]	Lissowska, J., Gaudet, M.M., Brinton, L.A. et al. Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: A population-based case-control study and meta-analyses Int. J. Cancer, 120 (2007),pp. 2696-2703
[38]	Luebeck, E.G., Moolgavkar, S.H., Liu, A.Y. et al. Does folic acid supplementation prevent or promote colorectal cancer? Results from model-based predictions Cancer Epidemiol. Biomarkers Prev., 17 (2008),pp. 1360-1367
[39]	Machlin, L.J.
[40]	Macis, D., Maisonneuve, P., Johansson, H. et al. Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: A nested-case-control study and a pooled meta-analysis Breast Cancer Res. Treat., 106 (2007),pp. 263-271
[41]	Mandola, M.V., Stoehlmacher, J., Zhang, W. et al. Pharmacogenetics, 14 (2004),pp. 319-327
[42]	Maring, J.G., Groen, H.J., Wachters, F.M. et al. Genetic factors influencing pyrimidine-antagonist chemotherapy Pharmacogenomics J., 5 (2005),pp. 226-243
[43]	Martin, D.N., Boersma, B.J., Howe, T.M. et al. BMC Cancer, 6 (2006),p. 257
[44]	Maunsell, E., Drolet, M., Brisson, J. et al. Dietary change after breast cancer: Extent, predictors, and relation with psychological distress J. Clin. Oncol., 20 (2002),pp. 1017-1025
[45]	McBride, C.M., Clipp, E., Peterson, B.L. et al. Psychological impact of diagnosis and risk reduction among cancer survivors Psychooncology, 9 (2000),pp. 418-427
[46]	McEligot, A.J., Largent, J., Ziogas, A. et al. Dietary fat, fiber, vegetable, and micronutrients are associated with overall survival in postmenopausal women diagnosed with breast cancer Nutr. Cancer, 55 (2006),pp. 132-140
[47]	Miller, J.W., Nadeau, M.R., Smith, J. et al. Folate-deficiency-induced homocysteinaemia in rats: Disruption of S-adenosylmethionine's co-ordinate regulation of homocysteine metabolism Biochem. J., 298 (1994),pp. 415-419
[48]	Niculescu, M.D. Diet, methyl donors and DNA methylation: Interactions between dietary folate, methionine and choline J. Nutr., 132 (2002),pp. 2333S-2335S
[49]	Nijhout, H.F., Reed, M.C., Anderson, D.F. et al. Long-range allosteric interactions between the folate and methionine cycles stabilize DNA methylation reaction rate Epigenetics, 1 (2006),pp. 81-87
[50]	Nijhout, H.F., Reed, M., Lam, S. et al. In silico experimentation with a model of hepatic mitochondrial folate metabolism Theor. Biol. Med. Model., 3 (2006),p. 40
[51]	Nijhout, H.F., Reed, M.C., Budu, P. et al. A mathematical model of the folate cycle: New insights into folate homeostasis J. Biol. Chem., 279 (2004),pp. 55008-55016
[52]	Paz, M.F., Avila, S., Fraga, M.F. et al. Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors Cancer Res., 62 (2002),pp. 4519-4524
[53]	Pullarkat, S.T., Stoehlmacher, J., Ghaderi, V. et al. Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy Pharmacogenomics J., 1 (2001),pp. 65-70
[54]	Rampersaud, G.C., Kauwell, G.P., Hutson, A.D. et al. Genomic DNA methylation decreases in response to moderate folate depletion in elderly women Am. J. Clin. Nutr., 72 (2000),pp. 998-1003
[55]	Reed, M.C., Nijhout, H.F., Neuhouser, M.L. et al. A mathematical model gives insights into nutritional and genetic aspects of folate-mediated one-carbon metabolism J. Nutr., 136 (2006),pp. 2653-2661
[56]	Rohan, T.E., Jain, M.G., Howe, G.R. et al. Dietary folate consumption and breast cancer risk J. Natl. Cancer Inst., 92 (2000),pp. 266-269
[57]	Rossi, E., Hung, J., Beilby, J.P. et al. Folate levels and cancer morbidity and mortality: Prospective cohort study from Busselton, Western Australia Ann. Epidemiol., 16 (2006),pp. 206-212
[58]	Russo, J., Yang, X., Hu, Y.F. et al. Biological and molecular basis of human breast cancer Front. Biosci., 3 (1998),pp. D944-D960
[59]	Salminen, E.K. Does breast cancer change patients' dietary habits? Eur J. Clin. Nutr., 54 (2000),pp. 844-848
[60]	Sauberlich, H.E., Kretsch, M.J., Skala, J.H. et al. Folate requirement and metabolism in nonpregnant women Am. J. Clin. Nutr., 46 (1987),pp. 1016-1028
[61]	Sellers, T.A., Kushi, L.H., Cerhan, J.R. et al. Dietary folate intake, alcohol, and risk of breast cancer in a prospective study of postmenopausal women Epidemiology, 12 (2001),pp. 420-428
[62]	Sellers, T.A., Alberts, S.R., Vierkant, R.A. et al. High-folate diets and breast cancer survival in a prospective cohort study Nutr. Cancer, 44 (2002),pp. 139-144
[63]	Shrubsole, M.J., Shu, X.O., Ruan, Z.X. et al. Breast Cancer Res. Treat., 91 (2005),pp. 73-79
[64]	Shrubsole, M.J., Gao, Y., Cai, Q. et al. Cancer Epidemiol. Biomarkers Prev., 15 (2006),pp. 586-588
[65]	Sohn, K., Croxford, R., Yates, Z. et al. Effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate J. Natl. Cancer Inst., 96 (2004),pp. 134-144
[66]	Stern, L.L., Mason, J.B., Selhub, J. et al. Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene Cancer Epidemiol. Biomarkers Prev., 9 (2000),pp. 849-853
[67]	Stevens, V.L., McCullough, M.L., Pavluck, A.L. et al. Association of polymorphisms in one-carbon metabolism genes and postmenopausal breast cancer incidence Cancer Epidemiol. Biomarkers Prev., 16 (2007),pp. 1140-1147
[68]	Stevenson, J.P., Redlinger, M., Kluijtmans, L.A. et al. Phase I clinical and pharmacogenetic trial of irinotecan and raltitrexed administered every 21 days to patients with cancer J. Clin. Oncol., 19 (2001),pp. 4081-4087
[69]	Stolzenberg-Solomon, R.Z., Chang, S.C., Leitzmann, M.F. et al. Folate intake, alcohol use, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Am. J. Clin. Nutr., 83 (2006),pp. 895-904
[70]	Toffoli, G., Veronesi, A., Boiocchi, M. et al. Ann. Oncol., 11 (2000),pp. 373-374
[71]	Ulrich, C.M., Curtin, K., Samowitz, W. et al. J. Nutr., 135 (2005),pp. 2462-2467
[72]	Ulrich, C.M., Bigler, J., Velicer, C.M. et al. Searching expressed sequence tag databases: Discovery and confirmation of a common polymorphism in the Thymidylate Synthase gene Cancer Epidemiol. Biomarkers Prev., 9 (2000),pp. 1381-1385
[73]	Ulrich, C.M., Nijhout, H.F., Reed, M.C. Mathematical modeling: Epidemiology meets systems biology Cancer Epidemiol. Biomarkers Prev., 15 (2006),pp. 827-829
[74]	Ulrich, C.M. Folate and cancer prevention: A closer look at a complex picture Am. J. Clin. Nutr., 86 (2007),pp. 271-273
[75]	Ulvik, A., Ueland, P.M., Fredriksen, A. et al. Functional inference of the methylenetetrahydrofolate reductase 677C>T and 1298A>C polymorphisms from a large-scale epidemiological study Hum. Genet., 121 (2007),pp. 57-64
[76]	van Engeland, M., Weijenberg, M.P., Roemen, G.M. et al. Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: The Netherlands cohort study on diet and cancer Cancer Res., 63 (2003),pp. 3133-3137
[77]	Velicer, C.M., Ulrich, C.M. Vitamin and mineral supplement use among US adults after cancer diagnosis: A systematic review J. Clin. Oncol., 26 (2008),pp. 665-673
[78]	Weisberg, I.S., Jacques, P.F., Selhub, J. et al. Atherosclerosis, 156 (2001),pp. 409-415
[79]	Widschwendter, M., Jones, P.A. DNA methylation and breast carcinogenesis Oncogene, 21 (2002),pp. 5462-5482
[80]	Wilson, A., Platt, R., Wu, Q. et al. Mol. Genet. Metab., 67 (1999),pp. 317-323
[81]	Xu, X., Gammon, M.D., Wetmur, J.G. et al. Am. J. Clin. Nutr., 85 (2007),pp. 1098-1102
[82]	Xu, X., Gammon, M.D., Zhang, H. et al. Polymorphisms of one-carbon metabolizing genes and risk of breast cancer in a population-based study Carcinogenesis, 28 (2007),pp. 1504-1509
[83]	Xu, X., Gammon, M.D., Zeisel, S.H. et al. Choline metabolism and risk of breast cancer in a population-based study FASEB J., 22 (2008),pp. 2045-2052
[84]	Xu, X., Gammon, M.D., Wetmur, J.G. et al. B-vitamin intake, one-carbon metabolism, and survival in a population-based study of women with breast cancer Cancer Epidemiol. Biomarkers Prev., 17 (2008),pp. 2109-2116
[85]	Young, R.C. Mechanisms to improve chemotherapy effectiveness Cancer, 65 (1990),pp. 815-822
[86]	Zhang, S., Hunter, D.J., Hankinson, S.E. et al. A prospective study of folate intake and the risk of Breast Cancer JAMA, 281 (1999),pp. 1632-1637
[87]	Zintzaras, E. Methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: A meta-analysis Clin. Genet., 69 (2006),pp. 327-336